12 citations as recorded by crossref.

1. In vitro antibiotic activity against intraosteoblastic Staphylococcus aureus: a narrative review of the literature F. Marro et al. 10.1093/jac/dkab301
2. Bone mineral as a drug-seeking moiety and a waste dump D. Raina et al. 10.1302/2046-3758.910.BJR-2020-0097.R1
3. CORR Insights®: Lower Success Rate of Débridement and Implant Retention in Late Acute versus Early Acute Periprosthetic Joint Infection Caused by Staphylococcus spp. Results from a Matched Cohort Study J. Drew 10.1097/CORR.0000000000001283
4. Prosthetic Knee Infection with Coagulase-Negative Staphylococcus: A Harbinger of Poor Outcomes L. Charalambous et al. 10.1016/j.arth.2022.02.050
5. Comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020) H. Scheper & M. de Boer 10.5194/jbji-6-17-2020
6. Risk Factors of DAIR Failure and Validation of the KLIC Score: A Multicenter Study of Four Hundred Fifty-Five Patients M. Bernaus et al. 10.1089/sur.2021.320
7. Reply to Scheper and de Boer's comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020) A. Becker et al. 10.5194/jbji-6-19-2020
8. If, When, and How to Use Rifampin in Acute Staphylococcal Periprosthetic Joint Infections, a Multicentre Observational Study M. Beldman et al. 10.1093/cid/ciab426
9. Outcome of Debridement, Antibiotics, and Implant Retention for Staphylococcal Hip and Knee Prosthetic Joint Infections, Focused on Rifampicin Use: A Systematic Review and Meta-Analysis H. Scheper et al. 10.1093/ofid/ofab298
10. Delayed Rifampin Administration in the Antibiotic Treatment of Periprosthetic Joint Infections Significantly Reduces the Emergence of Rifampin Resistance A. Darwich et al. 10.3390/antibiotics10091139
11. Rifampin, Rifapentine, and Rifabutin Are Active against Intracellular Periprosthetic Joint Infection-Associated Staphylococcus epidermidis C. Fisher & R. Patel 10.1128/AAC.01275-20
12. Quality of life, infection control, and complication rates using a novel custom-made articulating hip spacer during two-stage revision for periprosthetic joint infection A. Lunz et al. 10.1007/s00402-021-04274-4